The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Psoriasis assessment tools in clinical trials
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use
FINLAY, A. Y., & KHAN, G. K. (1994) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1994.tb01167.x · Cited by 5,586
Severe Psoriasis – Oral Therapy with a New Retinoid
Fredriksson, T., & Pettersson, U. (2009) · Dermatologica · doi:10.1159/000250839 · Cited by 2,718
Psoriasis causes as much disability as other major medical diseases
Rapp, S. R., Feldman, S. R., Exum, M. L., Fleischer, A. B., & Reboussin, D. M. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70112-x · Cited by 1,491
Self-citationEtanercept as Monotherapy in Patients with Psoriasis
Leonardi, C. L., Powers, J. L., Matheson, R. T., Goffe, B. S., Zitnik, R., Wang, A., & Gottlieb, A. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030409 · Cited by 1,175
Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire
Brazier, J., Jones, N., & Kind, P. (1993) · Quality of Life Research · doi:10.1007/bf00435221 · Cited by 704
Langley, R. G., & Ellis, C. N. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.04.012 · Cited by 614
Chren, M.-M. (1997) · Archives of Dermatology · doi:10.1001/archderm.1997.03890470111018 · Cited by 480
A Randomized Trial of Etanercept as Monotherapy for Psoriasis
Gottlieb, A. B. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.12.1627 · Cited by 470
Chren, M. (1997) · Archives of Dermatology · doi:10.1001/archderm.133.11.1433 · Cited by 446
Efalizumab for Patients With Moderate to Severe Plaque Psoriasis: A Randomized Controlled Trial
Gordon, K. B., Papp, K. A., Hamilton, T. K., Walicke, P. A., Dummer, W., Li, N., Bresnahan, B. W., Menter, A., & for the Efalizumab Study Group (2003) · JAMA · doi:10.1001/jama.290.23.3073 · Cited by 391
Critical review of the international assessments of health-related quality of life
Anderson, R. T., Aaronson, N. K., & Wilkin, D. (1993) · Quality of Life Research · doi:10.1007/bf00422215 · Cited by 346
Ashcroft, Po, L. W., Williams, & Griffiths (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02963.x · Cited by 287
Carlin, C. S., Feldman, S. R., Krueger, J. G., Menter, A., & Krueger, G. G. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.09.014 · Cited by 278
Self-citationKrueger, J. G., Wolfe, J. T., Nabeya, R. T., Vallat, V. P., Gilleaudeau, P., Heftler, N. S., Austin, L. M., & Gottlieb, A. B. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.6.2057 · Cited by 248
Physical and psychologic measures are necessary to assess overall psoriasis severity
Kirby, B., Richards, H. L., Woo, P., Hindle, E., Main, C. J., & Griffiths, C. E. M. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.114592 · Cited by 162
Infliximab monotherapy provides rapid and sustained benefit for plaque-type psoriasis
Gottlieb, A. B., Chaudhari, U., Mulcahy, L., Li, S., Dooley, L. T., & Baker, D. G. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.307 · Cited by 156
The Salford Psoriasis Index: an holistic measure of psoriasis severity
Kirby, B., Fortune, D. G., Bhushan, M., Chalmers, R. J. G., & Griffiths, C. E. M. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.03418.x · Cited by 152
Gottlieb, A. B. (2003) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(03)01143-5 · Cited by 118
Gottlieb, A. B., Chaudhari, U., Baker, D. G., Perate, M., & Dooley, L. T. (2003) · PubMed · Cited by 87
Quality of life measures in psoriasis: a critical appraisal of their quality
Ashcroft, D. M., Po, A. L. W., Williams, H. C., & Griffiths, C. E. M. (1998) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.1998.00181.x · Cited by 62
Efficacy of Acitretin and Commercial Tanning Bed Therapy for Psoriasis
Carlin, C. S., Callis, K. P., & Krueger, G. G. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.4.436 · Cited by 51
Self-citation
Cited by
Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
Papp, K. A., Leonardi, C., Menter, A., Ortonne, J.-P., Krueger, J. G., Kricorian, G., Aras, G., Li, J., Russell, C. B., Thompson, E. H. Z., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109017 · Cited by 941
Greb, J. E., Goldminz, A. M., Elder, J. T., Lebwohl, M. G., Gladman, D. D., Wu, J. J., Mehta, N. N., Finlay, A. Y., & Gottlieb, A. B. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.82 · Cited by 922
Hueber, W., Patel, D. D., Dryja, T., Wright, A. M., Koroleva, I., Bruin, G., Antoni, C., Draelos, Z., Gold, M. H., the Psoriasis Study Group, et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001107 · Cited by 860
Mease, P. J., van der Heijde, D., Ritchlin, C. T., Okada, M., Cuchacovich, R. S., Shuler, C. L., Lin, C.-Y., Braun, D. K., Lee, C. H., & Gladman, D. D. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209709 · Cited by 580
Lebwohl, M. G., Bachelez, H., Barker, J., Girolomoni, G., Kavanaugh, A., Langley, R. G., Paul, C. F., Puig, L., Reich, K., & van de Kerkhof, P. C. M. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.12.018 · Cited by 515
Metadata
- Authors
- Feldman, S. R., & Krueger, G. G.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2005-03
- Volume
- 64
- Pages
- ii65-ii68
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2128551077
- Cited by
- 557
- References
- 21
- FWCI
- 9.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.